Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: J Subst Abuse Treat. 2014 Feb 10;47(1):93–101. doi: 10.1016/j.jsat.2014.01.007

Table 3.

Concordance of Time 1 and Time 2 results for classification of low risk versus moderate-high risk use (N=101).

Individuals in risk category
N (%)
Concordant risk levela
N (%)
Increased risk levelb
N
Decreased risk levelc
N
McNemar’s test P-valued Kappae

Substance Use Variable Time 1 Time 2

Tobacco 94 (93.1) 5 2 0.453 0.850
 Low risk 66 (65.3) 63 (62.4)
 Mod OR high risk 35 (34.7) 38 (37.6)

Alcohol 95 (94.1) 2 4 0.687 0.836
 Low risk 76 (75.2) 78 (77.2)
 Mod OR high risk 25 (24.8) 23 (22.8)

Drugs (summary category)f 94 (93.1) 2 5 0.453 0.861
 Low risk 53 (52.5) 56 (55.4)
 Mod OR high risk 48 (47.5) 45 (44.6)

Marijuana 92 (91.1) 6 3 0.508 0.764
 Low risk 77 (76.2) 74 (73.3)
 Mod OR high risk 24 (23.8) 27 (26.7)

Cocaine 95 (94.1) 4 2 0.687 0.855
 Low risk 73 (72.3) 71 (70.3)
 Mod OR high risk 28 (27.7) 30 (29.7)

Prescription opioids 92 (91.1) 4 5 1.000 --
 Low risk 85 (84.2) 86 (85.1)
 Mod OR high risk 16 (15.8) 15 (14.9)

Sedatives 91 (90.1) 4 6 0.754 --
 Low risk 88 (87.1) 90 (89.1)
 Mod OR high risk 13 (12.9) 11 (10.9)

Hallucinogens 96 (95.0) 0 5 0.063 --
 Low risk 91 (90.1) 96 (95.0)
 Mod OR high risk 10 (9.9) 5 (5.0)

Heroin 96 (95.0) 1 4 0.375 --
 Low risk 84 (83.2) 87 (86.1)
 Mod OR high risk 17 (16.8) 14 (13.9)

Prescription stimulants 99 (98.0) 1 1 1.000 --
 Low risk 97 (96.0) 97 (96.0)
 Mod OR high risk 4 (4.0) 4 (4.0)

Inhalants 96 (95.0) 2 3 1.000 --
 Low risk 96 (95.0) 97 (96.0)
 Mod OR high risk 5 (5.0) 4 (4.0)

Methamphetamine 97 (96.0) 3 1 0.625 --
 Low risk 96 (95.0) 94 (93.1)
 Mod OR high risk 5 (5.0) 7 (6.9)

Other Drug 95 (94.1) 2 4 0.687 --
 Low risk 94 (93.1) 96 (95.0)
 Mod OR high risk 7 (6.9) 5 (5.0)
a

Concordant risk level = remained in same risk level between T1 and T2

b

Increased risk level = went from low to moderate-high risk

c

Decreased risk level = went from moderate-high to low risk

d

P-value for McNemar’s test of correlated proportions, comparing the proportion of individuals having low risk versus moderate-high risk scores at T1 and T2. A non-significant P-value implies that there was no significant change in scores for the study population between T1 and T2.

e

Cohen’s Kappa was calculated for all substances having 20% or greater prevalence of moderate-high risk use in the study population. All kappa values shown were statistically significant at the P<.001 level.

f

Risk level is based on highest risk score for any substance in this category